FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel medication for treatment of purulent-inflammatory processes of skin and mucous membranes of different etiology. Medication is made in form of gel and contains the following ingredients with the following ratio of components in g per 100 g: biocomplex of cobalt (II) with metronidasole 0.20-0.50. biocomplex of cobalt (II) with ampicillin 0.20-0.50, trimecaine 3.00-5.00, methyluracyl 1.00-3.00, dimexide 10.00, glycerol 5.00-10.00, hydrophilic base 3.00-7.00, water 77.60-64.00.
EFFECT: extension of assortment of wound-healing medications.
3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIMICROBIAL COMPOSITION FOR TREATMENT OF WOUNDS AND BURNS | 2011 |
|
RU2481834C2 |
LOCAL PHARMACEUTICAL ANTIBACTERIAL COMPOSITION OF ACTIVE BIOMETALLIC COMPLEXES | 2011 |
|
RU2489147C2 |
METHOD OF VARIOUS SUPPULATIVE-INFLAMMATORY SKIN AND MUCOUS PROCESS TREATMENT | 2005 |
|
RU2326681C2 |
AGENT FOR TREATING PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2015 |
|
RU2601897C1 |
AGENT FOR WOUNDS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF SKIN, APPENDAGES AND MUCOUS MEMBRANES | 2010 |
|
RU2452475C2 |
AGENT FOR PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2017 |
|
RU2646462C1 |
AGENT FOR TREATING PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2015 |
|
RU2603490C1 |
AGENT FOR TREATING PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2015 |
|
RU2605343C1 |
AGENT FOR PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2017 |
|
RU2641095C1 |
ANTIBACTERIAL AND NECROLYTIC EXTERNAL AND LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367457C2 |
Authors
Dates
2013-05-20—Published
2011-08-31—Filed